Matches in SemOpenAlex for { <https://semopenalex.org/work/W2895531718> ?p ?o ?g. }
- W2895531718 endingPage "2521" @default.
- W2895531718 startingPage "2513" @default.
- W2895531718 abstract "Acute myeloid leukemia (AML) is a clonal myeloid neoplasm that typically arises de novo; however, some cases evolve from a preleukemic state, such as myelodysplastic syndrome (MDS). Such secondary AMLs and those with typical MDS-related clinical features are known as AMLs with myelodysplasia-related changes (AML-MRC). Because patients with AML-MRC have poor prognosis, more accurate diagnostic approaches are required. In this study, we performed targeted sequencing of 54 genes in 3 cell populations (granulocyte, blast, and T-cell fractions) using samples from 13 patients with MDS, 16 patients with clinically diagnosed AML-MRC, 4 patients with suspected AML-MRC but clinically diagnosed as AML not otherwise specified (AML-NOS), and 11 patients with de novo AML. We found that overlapping mutations, defined as those shared at least by the blast and granulocyte fractions, were significantly enriched in patients with MDS and AML-MRC, including those with suspected AML-MRC, indicating a substantial history of clonal hematopoiesis. In contrast, blast-specific nonoverlapping mutations were significantly enriched in patients with de novo AML. Furthermore, the presence of overlapping mutations, excluding DNMT3A, TET2, and ASXL1, effectively segregated patients with MDS and AML-MRC or suspected AML-MRC from patients with de novo AML. Additionally, the presence of ≥3 mutations in the blast fraction was useful for distinguishing patients with AML-MRC from those with MDS. In conclusion, our approach is useful for classifying clinically diagnosable AML-MRC and identifying clinically diagnosed AML-NOS as latent AML-MRC. Additional prospective studies are needed to confirm the utility of this approach." @default.
- W2895531718 created "2018-10-12" @default.
- W2895531718 creator A5003820252 @default.
- W2895531718 creator A5012455252 @default.
- W2895531718 creator A5018044109 @default.
- W2895531718 creator A5027362548 @default.
- W2895531718 creator A5035236394 @default.
- W2895531718 creator A5036953695 @default.
- W2895531718 creator A5045246763 @default.
- W2895531718 creator A5060243004 @default.
- W2895531718 creator A5069658499 @default.
- W2895531718 creator A5073827722 @default.
- W2895531718 creator A5078146127 @default.
- W2895531718 creator A5079588938 @default.
- W2895531718 creator A5090788230 @default.
- W2895531718 date "2018-10-03" @default.
- W2895531718 modified "2023-10-12" @default.
- W2895531718 title "Cell-lineage level–targeted sequencing to identify acute myeloid leukemia with myelodysplasia-related changes" @default.
- W2895531718 cites W1493011226 @default.
- W2895531718 cites W1534069493 @default.
- W2895531718 cites W1534965621 @default.
- W2895531718 cites W1920585977 @default.
- W2895531718 cites W1978575720 @default.
- W2895531718 cites W1980860344 @default.
- W2895531718 cites W1991345847 @default.
- W2895531718 cites W1992826811 @default.
- W2895531718 cites W1993236149 @default.
- W2895531718 cites W2012753533 @default.
- W2895531718 cites W2013112095 @default.
- W2895531718 cites W2014215749 @default.
- W2895531718 cites W2026134786 @default.
- W2895531718 cites W2030736903 @default.
- W2895531718 cites W2055521874 @default.
- W2895531718 cites W2058166031 @default.
- W2895531718 cites W2073440691 @default.
- W2895531718 cites W2075877031 @default.
- W2895531718 cites W2076031927 @default.
- W2895531718 cites W2086858024 @default.
- W2895531718 cites W2097519948 @default.
- W2895531718 cites W2107027906 @default.
- W2895531718 cites W2126816979 @default.
- W2895531718 cites W2135898863 @default.
- W2895531718 cites W2148965443 @default.
- W2895531718 cites W2149858388 @default.
- W2895531718 cites W2157783208 @default.
- W2895531718 cites W2168342352 @default.
- W2895531718 cites W2247653092 @default.
- W2895531718 cites W2264873876 @default.
- W2895531718 cites W2331819673 @default.
- W2895531718 cites W2337566632 @default.
- W2895531718 cites W2339658711 @default.
- W2895531718 cites W2412183643 @default.
- W2895531718 cites W2419140434 @default.
- W2895531718 cites W2512063631 @default.
- W2895531718 cites W2551607099 @default.
- W2895531718 cites W2559082338 @default.
- W2895531718 cites W2561161989 @default.
- W2895531718 cites W2582377716 @default.
- W2895531718 cites W2582892663 @default.
- W2895531718 cites W2587066646 @default.
- W2895531718 cites W2606218280 @default.
- W2895531718 cites W2623932473 @default.
- W2895531718 cites W835691338 @default.
- W2895531718 doi "https://doi.org/10.1182/bloodadvances.2017010744" @default.
- W2895531718 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6177645" @default.
- W2895531718 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30282643" @default.
- W2895531718 hasPublicationYear "2018" @default.
- W2895531718 type Work @default.
- W2895531718 sameAs 2895531718 @default.
- W2895531718 citedByCount "10" @default.
- W2895531718 countsByYear W28955317182019 @default.
- W2895531718 countsByYear W28955317182020 @default.
- W2895531718 countsByYear W28955317182021 @default.
- W2895531718 countsByYear W28955317182022 @default.
- W2895531718 countsByYear W28955317182023 @default.
- W2895531718 crossrefType "journal-article" @default.
- W2895531718 hasAuthorship W2895531718A5003820252 @default.
- W2895531718 hasAuthorship W2895531718A5012455252 @default.
- W2895531718 hasAuthorship W2895531718A5018044109 @default.
- W2895531718 hasAuthorship W2895531718A5027362548 @default.
- W2895531718 hasAuthorship W2895531718A5035236394 @default.
- W2895531718 hasAuthorship W2895531718A5036953695 @default.
- W2895531718 hasAuthorship W2895531718A5045246763 @default.
- W2895531718 hasAuthorship W2895531718A5060243004 @default.
- W2895531718 hasAuthorship W2895531718A5069658499 @default.
- W2895531718 hasAuthorship W2895531718A5073827722 @default.
- W2895531718 hasAuthorship W2895531718A5078146127 @default.
- W2895531718 hasAuthorship W2895531718A5079588938 @default.
- W2895531718 hasAuthorship W2895531718A5090788230 @default.
- W2895531718 hasBestOaLocation W28955317181 @default.
- W2895531718 hasConcept C126322002 @default.
- W2895531718 hasConcept C143998085 @default.
- W2895531718 hasConcept C2778461978 @default.
- W2895531718 hasConcept C2778729363 @default.
- W2895531718 hasConcept C2779282312 @default.
- W2895531718 hasConcept C2780007613 @default.
- W2895531718 hasConcept C2780817109 @default.
- W2895531718 hasConcept C502942594 @default.